| Apr 29, 2013 |
Apr 27, 2015 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
43.8
|
-140,000
|
-0.46%
|
✗
|
$11.2K |
| Mar 11, 2014 |
Mar 17, 2014 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
22.5
|
-239,367
|
-1.17%
|
✗
|
$144K |
| Mar 6, 2014 |
Mar 10, 2014 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
17.5
|
-1,824,500
|
-3.19%
|
✗
|
$1.4M |
| Jan 13, 2014 |
Jan 17, 2014 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
22.5
|
-805,583
|
-2.38%
|
✗
|
$147.4K |
| Jan 3, 2013 |
Jan 7, 2014 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
22.5
|
-531,185
|
-1.57%
|
✗
|
$79.7K |
| Nov 15, 2013 |
Jan 6, 2014 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
36.3
|
-253,050
|
-0.74%
|
✗
|
$29.7K |
| Nov 26, 2013 |
Dec 13, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
36.3
|
-298,626
|
-0.69%
|
✗
|
$37.3K |
| Dec 2, 2013 |
Dec 4, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
43.8
|
-100,000
|
-0.47%
|
✗
|
$12.5K |
| Nov 11, 2013 |
Nov 29, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
32.5
|
-421,000
|
-0.65%
|
✗
|
$50.9K |
| Nov 14, 2013 |
Nov 19, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
22.5
|
-1,974,140
|
-2.11%
|
✗
|
$230.8K |
| Nov 6, 2013 |
Nov 8, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
43.8
|
-122,200
|
-0.36%
|
✗
|
$15.1K |
| Oct 28, 2013 |
Oct 30, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
36.3
|
-279,300
|
-0.81%
|
✗
|
$35.8K |
| May 9, 2013 |
May 13, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
26.3
|
-391,500
|
-1.82%
|
✗
|
$27.8K |
| Apr 26, 2013 |
Apr 30, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Buy |
95.0
|
+4,455,827
|
26.21%
|
✗
|
$164.4K |
| Apr 25, 2013 |
Apr 29, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
20.0
|
-13,891,407
|
-13.10%
|
✗
|
$535.2K |
| Mar 25, 2013 |
Mar 27, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Buy |
97.5
|
+6,775,068
|
42.65%
|
✗
|
$250K |
| Mar 21, 2013 |
Mar 25, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
20.0
|
-13,550,136
|
-46.03%
|
✗
|
$500K |
| Jan 22, 2013 |
Jan 25, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
26.3
|
-356,700
|
-2.61%
|
✗
|
$32.1K |
| Jan 11, 2013 |
Jan 14, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
22.5
|
-2,339,000
|
-23.47%
|
✗
|
$211.9K |
| Dec 26, 2012 |
Dec 31, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
22.5
|
-561,000
|
-5.33%
|
✗
|
$50.9K |
| Dec 19, 2012 |
Dec 21, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
20.0
|
-17,248,720
|
-31.18%
|
✗
|
$649.8K |
| May 4, 2012 |
May 4, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
20.0
|
-9,214,097
|
-24.91%
|
✗
|
$340K |
| Apr 18, 2012 |
Apr 26, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
20.0
|
-24,281,850
|
-39.63%
|
✗
|
$896K |
| Mar 23, 2012 |
Mar 27, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
CFO |
Sell |
20.0
|
-2,725,000
|
-4.26%
|
✗
|
$256.5K |
| Mar 14, 2012 |
Mar 20, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Sell |
52.5
|
-85,000
|
-0.13%
|
✗
|
$8.5K |
| Feb 2, 2011 |
Mar 17, 2011 |
ELITE PHARMACEUTICALS INC /NV/
|
Chief Scientific Officer |
Buy |
91.3
|
+407,949
|
100.00%
|
✗
|
$16.3K |